Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN113045484B details efficient synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel method for lapatinib intermediates using recyclable Pd catalyst. Enhances purity and reduces environmental impact for pharma manufacturing.
Novel carbamate protection route for dobutamine hydrochloride eliminates hazardous reagents and ensures high purity for reliable pharmaceutical intermediate supply chains.
Advanced chiral resolution process for S-(-)-Nadifloxacin. Enhances solubility and bioavailability. Cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN106795542B details (R)-selective cupin enzymes for chiral beta-nitroalcohol synthesis, offering high purity and cost reduction in API manufacturing.
Advanced patent CN101351438A details a safer, scalable route to Tamiflu intermediates using transketalization, eliminating toxic reagents and solid isolations for cost-effective manufacturing.
Novel synthetic route for 4-chloropyrrolo pyrimidine ensures safety and high yield. Ideal for reliable pharmaceutical intermediate supplier seeking cost reduction and scale-up.
Advanced synthesis of Dutasteride via DDQ dehydrogenation and triphosgene amidation. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN104744377A reveals a novel synthesis route for rosuvastatin intermediates offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel itraconazole preparation method using epoxy propanol reduces costs and improves purity for pharmaceutical supply chains. This patent offers significant advantages for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102924429B details a novel synthesis for 2-amino-4,5-dioxo-4,5-dihydro-naphtho[1,2-b]thiophene-3-ethyl formate, offering a scalable route for topoisomerase II inhibitors with improved solubility.
Patent CN113735921B details a scalable synthesis for C-glycoside impurities, enhancing QC capabilities and reducing costs in API manufacturing for global supply chains.
Patent CN104530062B details a green L-proline catalyzed route for high-purity 1,4-naphthoquinone derivatives offering significant supply chain and cost advantages.
Patent CN114716449B reveals a scalable synthesis route for Huperzine A intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover the advanced one-pot synthesis for 1-oxacephalosporin-7α-methoxy-3-chloromethyl derivatives. Eliminate photo-irradiation for substantial cost reduction and scalable manufacturing.
Discover the novel Co-catalyzed process for 4-chloro-4'-hydroxybenzophenone. Enhanced purity, reduced waste, and scalable manufacturing for fenofibrate intermediates.
Novel synthesis route for Pterostilbene via aldol condensation and diazotization. Offers high purity and cost efficiency for pharmaceutical intermediates manufacturing.
Novel FeCl3-catalyzed route for Vinblastine Sulfate. High purity >98%, scalable process, cost-effective raw materials for oncology drugs.
Novel iron-catalyzed route for (S)-flurbiprofen ensures high optical purity and scalable manufacturing for global pharmaceutical supply chains reducing costs significantly.
Advanced Carfilzomib preparation using HATU condensation. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.